Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WW International, formerly known as Weight Watchers International, is a global wellness company that provides weight management and health services. In 2023, the company significantly expanded its healthcare footprint by acquiring Sequence, a subscription-based telehealth platform that provides access to clinical weight management, including GLP-1 medications. The company now integrates its traditional behavioral weight-loss programs with medical interventions, targeting the growing obesity market. WW operates a digital platform and provides nutritional guidance, community support, and clinical care through its WW Clinic. This pivot into clinical healthcare has made the company a significant player in the obesity medicine landscape, bridging the gap between lifestyle modification and pharmacological treatment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wellness Watchers International.